Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Antimycin A3 is a component of the antimycin A complex that is more polar than antimycin A1 (Item No. 19433) and antimycin A2 (Item No. 21997) but not antimycin A4 (Item No. 21999).1,2,3,4 Antimycin A3 binds to the Q(inner) site of mitochondrial complex III (cytochrome bc1) and inhibits mitochondrial respiration (IC50 = 38 nM in isolated rat liver mitochondria).5 It also inhibits ATP-citrate lyase with a Ki value of 60.1 µM, and it stimulates the production of reactive oxygen species.6,7 In molecular modeling studies, antimycin binds to a mutant form of Bcl-2 (hBcl-2Δ22) and has a Kd value of 0.82 µM for binding to a recombinant mutant form of Bcl-2 (rhBcl-2Δ22) in an isothermal calorimetry assay.8
WARNING This product is not for human or veterinary use.
1. The chemistry of antimycin A. VI. Separation and properties of antimycin A subcomponents. J. Am. Chem. Soc. 81(16), 4387-4390 (1959).
2. Preparative separation of six antimycin A components from antimycin fermentation broth by high-
3. The isolation and properties of antimycin A. J. Am Chem. Soc. 71(7), 2436-2437 (1949).
4. Antimycin A components. I. Isolation and biological activity. J. Antibiot. (Tokyo) 23(2), 75-80 (1970).
5. Inhibition of electron transport of rat liver mitochondria by unnatural (−)-
6. Antimycins, inhibitors of ATP-
7. UK-
8. Biophysical characterization of recombinant human Bcl-